How to publish with the Journal of Thoracic Oncology

JOIN OUR LIVE WEBINAR

Thursday 29 October at 13:00 (UTC)
Save

About this video

Finding the right journal to publish your research and structuring your research to publish in high impact journals can be a challenge. Learn techniques and strategies to publish in high impact journals like the Journal of Thoracic Oncology with Dr. Alex Adjei, Editor-in-Chief, Journal of Thoracic Oncology.

You can expect to learn about:
-Manuscript preparation tips
-Features of successful manuscripts
- Fatal errors in manuscripts that lead to outright rejection
- The Editorial process
-How to publish in JTO and its new spin-off JTO Clinical Research Reports
-New Initiatives at the Journal

About the presenter

Thumbnail
Dr. Alex Adjei
|

Editor-in-Chief, Journal of Thoracic Oncology.

Alex A. Adjei is a Professor of Oncology and Professor of Pharmacology in the Mayo College of Medicine. He is also a consultant in Medical Oncology at Mayo Clinic. Dr. Adjei is Director of the Early Cancer Therapeutics Program across all three Mayo Clinic sites, and leader of the Lung Cancer Program across all 3 Mayo Clinic sites. He is the Principal Investigator of the Mayo Phase I and Phase II NCI grants. Dr Adjei has served on a number of National Cancer Institute (US) Committees. He is currently co-chair of the Thoracic Malignancies Steering Committee. Dr Adjei is a past member of the IASLC Board of Directors. He is the Editor-in-Chief of the Journal of Thoracic Oncology and the inaugural Editor-in-Chief of JTO Clinical and Research Reports.. Dr Adjei’s research is focused on experimental therapeutics and clinical drug development. He received the first ASCO Drug Development Research Professorship 2012-2017, in recognition of his mentorship and his work in cancer drug development. He has authored 280 publications dealing primarily with preclinical pharmacology and phase I trials as well as novel therapeutics/phase II trials of lung cancer.             

 

Comments